SCHEMBL30767223

SCHEMBL30767223

O=C1CCC(n2nnc3ccc(N4CCCCC4)cc3c2=O)C(=O)N1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 12/20 0.51
IP6K1 Q92551 2/20 0.42
IP6K3 Q96PC2 1/20 0.40
DDB1 Q16531 10/20 0.39
IKZF3 Q9UKT9 3/20 0.39
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
HSD17B10 Q99714 2/20 0.37
WIZ O95785 1/20 0.37
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
IDO2 Q6ZQW0 1/20 0.37
MAP4K4 O95819 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30767222 0.92 CRBN (0.57) CRBNIP6K1DDB1IKZF3PDE3B
SCHEMBL27012609 0.91 CRBN (0.49) CRBNDDB1IKZF3IDO1TDO2
SCHEMBL22326226 0.87 CRBN (0.47) CRBNIP6K1DDB1IKZF3PDE3B
SCHEMBL22326268 0.84 CRBN (0.47) CRBNDDB1IKZF3ALDH1A1CYP1A2
SCHEMBL21751118 0.82 CRBN (0.55) CRBNDDB1IKZF3ALDH1A1CYP1A2
SCHEMBL24233170 0.81 CRBN (0.57) CRBNDDB1IKZF3ALDH1A1CYP1A2
SCHEMBL21751104 0.81 CRBN (0.54) CRBNDDB1IKZF3ALDH1A1CYP1A2
SCHEMBL23534466 0.81 CRBN (0.57) CRBNDDB1IKZF3ALDH1A1CYP1A2
SCHEMBL21751067 0.81 CRBN (0.54) CRBNDDB1IKZF3ALDH1A1CYP1A2
SCHEMBL21751098 0.81 CRBN (0.56) CRBNDDB1IKZF3ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018123-A1 COMPOUND FOR INHIBITING OR DISINTEGRATING ANDROGEN RECEPTOR, AND PHARMACEUTICAL USE THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2024-01-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018123-A1 COMPOUND FOR INHIBITING OR DISINTEGRATING ANDROGEN RECEPTOR, AND PHARMACEUTICAL USE THEREOF AR, NR5A1, SHBG CRBN 3597/4885IP6K1 3501/4885IP6K3 2908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.